As of 22 Sept 2026, Invicta Diagnostic Ltd share price is ₹65.00. The stock opened at ₹65.00 and had closed at ₹68.10 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹58.10 and a high of ₹105.00. In terms of performance, Invicta Diagnostic Ltd share price has decreased by 22.08% over the past six months and has decreased by 29.58% over the last year.
INVICTA Stock Price Chart
Invicta Diagnostic Ltd Overview
About INVICTA
Invicta Diagnostic is primarily engaged in the service of diagnostic chain offering comprehensive radiology and pathology solutions.
Invicta Diagnostic Ltd Historical Performance
Invicta Diagnostic Ltd Fundamentals
Invicta Diagnostic Ltd Financials
| Indicator | Mar 26 | Mar 25 |
|---|---|---|
| Revenue | 21.41 | 17.73 |
| EBITDA | 8.78 | 7.66 |
| Net Profit | 5.53 | 5.23 |
| EPS | 5.56 | 6.21 |
Invicta Diagnostic Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 65.63 |
| Resistance 1 (R1) | 69.33 |
| Pivot Point | 66.87 |
INVICTA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Ketan Jayantilal Jain | Non Executive Director |
| Sanket Vinod Jain | Chairman |
| Aayush Kamleshbhai Shah | Independent Director |
Invicta Diagnostic Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,902.00-0.11% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,052.50-1.32% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹893.55+0.01% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Invicta Diagnostic Ltd today is ₹65.00 on NSE and ₹65.00 on BSE.
- The 52-week high of Invicta Diagnostic Ltd is ₹105.00, while the 52-week low is ₹58.10.
- The current market capitalisation of Invicta Diagnostic Ltd is approximately ₹86 crore.
- The P/E (Price-to-Earnings) ratio of Invicta Diagnostic Ltd is 15.83. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Invicta Diagnostic Ltd is 1.46. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Invicta Diagnostic Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for INVICTA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Invicta Diagnostic Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Invicta Diagnostic Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 66.70% promoters, 4.20% FIIs, 4.30% DIIs, and 18.71% public shareholders.

